Compare LONA & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LONA | AEON |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 25.2M |
| IPO Year | 2020 | N/A |
| Metric | LONA | AEON |
|---|---|---|
| Price | $5.06 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 53.4K | ★ 236.3K |
| Earning Date | 02-26-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.20 | $0.38 |
| 52 Week High | $8.36 | $10.01 |
| Indicator | LONA | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 32.91 | 42.91 |
| Support Level | $4.42 | $1.01 |
| Resistance Level | $4.92 | $1.13 |
| Average True Range (ATR) | 0.40 | 0.08 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 37.48 | 7.69 |
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.